Suchergebnisse - "SUBKLEWE MARION"

PubPharm (326)

81

The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL

enthalten in: American Journal of Hematology | 2023

von Rejeski, K. | Wang, Y. | Albanyan, O. | +17

82

Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy : Roadmap from an ELN‐DAVID expert panel

enthalten in: American Journal of Hematology | 2023

von Ravandi, F. | Cloos, J. | Buccisano, F. | +14

83

Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T-cell therapy

enthalten in: European journal of nuclear medicine and molecular imaging | 2022

von Winkelmann, M. | Blumenberg, V. | Rejeski, K. | +10

84

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

enthalten in: Journal of hematology & oncology | 2022

von Shah, B. | Ghobadi, A. | Oluwole, O. | +27

85

Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study

enthalten in: Journal of hematology & oncology | 2022

von Shah, B. | Ghobadi, A. | Oluwole, O. | +27

86

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T therapy for Richter-transformed DLBCL

enthalten in: Blood | 2022

von Rejeski, K. | Wu, Z. | Blumenberg, V. | +11

87

A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma

enthalten in: Cell reports. Medicine | 2022

von Fahrmann, J. | Saini, N. | Chia-Chi, C. | +28

88

A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphoma

enthalten in: Cell reports. Medicine | 15 November 2022

von Fahrmann, J. | Saini, N. | Chia-Chi, C. | +28

89

Chimeric Antigen Receptor T-cell Therapy : Imaging Response Criteria and Relation to Progression-free and Overall Survival

enthalten in: HemaSphere | 2022

von Winkelmann, M. | Rejeski, K. | Blumenberg, V. | +10

90

Treatment, outcome and re-vaccination of patients with SARS-CoV-2 vaccine-associated immune thrombocytopenia

enthalten in: Infection | 2022

von Ruzicka, M. | Wurm, S. | Lindner, L. | +9